Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Ginestier

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
EMBO Molecular Medicine|September 3, 2019
A genome-wide RNAi screen reveals essential therapeutic targets of breast cancer stem cellsAbir Arfaoui, Claire Rioualen, Violette Azzoni, et al.
Plos Genetics|June 12, 2012
MicroRNA93 regulates proliferation and differentiation of normal and malignant breast stem cellsSuling Liu, Shivani H Patel, Christophe Ginestier, et al.
Cell|May 21, 2022
XIST loss impairs mammary stem cell differentiation and increases tumorigenicity through Mediator hyperactivationLaia Richart, Mary-Loup Picod-Chedotel, Michel Wassef, et al.
Oncotarget|February 18, 2015
Role of microRNA221 in regulating normal mammary epithelial hierarchy and breast cancer stem-like cellsJia Ke, Zhiju Zhao, Su-Hyung Hong, et al.
EMBO Molecular Medicine|February 18, 2011
ZNF703 gene amplification at 8p12 specifies luminal B breast cancerFabrice Sircoulomb, Nathalie Nicolas, Anthony Ferrari, et al.
Cancer Research|October 22, 2013
ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell programEmmanuelle Charafe-Jauffret, Christophe Ginestier, François Bertucci, et al.
Cancer Research|July 5, 2015
Depleting MET-Expressing Tumor Cells by ADCC Provides a Therapeutic Advantage over Inhibiting HGF/MET SignalingAnna Hultberg, Virginia Morello, Leander Huyghe, et al.
Iscience|November 24, 2021
CD95/Fas protects triple negative breast cancer from anti-tumor activity of NK cellsAbdul S Qadir, Jean Philippe Guégan, Christophe Ginestier, et al.
Oncotarget|July 25, 2016
Pregnane X-receptor promotes stem cell-mediated colon cancer relapseChris Planque, Fatemeh Rajabi, Fanny Grillet, et al.
Stem Cell Reports|February 11, 2014
Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterpartsSuling Liu, Yang Cong, Dong Wang, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
EMBO Molecular Medicine|September 3, 2019
A genome-wide RNAi screen reveals essential therapeutic targets of breast cancer stem cellsAbir Arfaoui, Claire Rioualen, Violette Azzoni, et al.
Plos Genetics|June 12, 2012
MicroRNA93 regulates proliferation and differentiation of normal and malignant breast stem cellsSuling Liu, Shivani H Patel, Christophe Ginestier, et al.
Cell|May 21, 2022
XIST loss impairs mammary stem cell differentiation and increases tumorigenicity through Mediator hyperactivationLaia Richart, Mary-Loup Picod-Chedotel, Michel Wassef, et al.
Oncotarget|February 18, 2015
Role of microRNA221 in regulating normal mammary epithelial hierarchy and breast cancer stem-like cellsJia Ke, Zhiju Zhao, Su-Hyung Hong, et al.
EMBO Molecular Medicine|February 18, 2011
ZNF703 gene amplification at 8p12 specifies luminal B breast cancerFabrice Sircoulomb, Nathalie Nicolas, Anthony Ferrari, et al.
Cancer Research|October 22, 2013
ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell programEmmanuelle Charafe-Jauffret, Christophe Ginestier, François Bertucci, et al.
Cancer Research|July 5, 2015
Depleting MET-Expressing Tumor Cells by ADCC Provides a Therapeutic Advantage over Inhibiting HGF/MET SignalingAnna Hultberg, Virginia Morello, Leander Huyghe, et al.
Iscience|November 24, 2021
CD95/Fas protects triple negative breast cancer from anti-tumor activity of NK cellsAbdul S Qadir, Jean Philippe Guégan, Christophe Ginestier, et al.
Oncotarget|July 25, 2016
Pregnane X-receptor promotes stem cell-mediated colon cancer relapseChris Planque, Fatemeh Rajabi, Fanny Grillet, et al.
Stem Cell Reports|February 11, 2014
Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterpartsSuling Liu, Yang Cong, Dong Wang, et al.
Pageof 10